Abstract:Objective To value the significance of the serum tumor markers carcinoembryonic antigen(CEA),CA199,and CA125 in the benign and malignant pancreatic diseases with and without obstructive jaundice.Methods The tumor markers CA199,CA125 and CEA in 60 patients with pancreatic neoplasm and 19 cases of patients with benign mass were detected.All the test of tumor markers and related reagents were used by chemiluminescent microparticle immunoassay(CMIA) to analyze the tumor markers in the differential diagnosis of pancreatic mass lesions.Results The diagnostic value of CA199 alone was the highest in differential diagnosis of pancreatic mass lesions.The sensitivity,specificity,the error rate and the missed diagnosis rate value of CA199 test were 66.7%,78.9%,22.1% and 33.3%,respectively(Youden index = 0.456).The sensitivity and specificity of a combined evaluation of both CA199 and CEA tests were 73.3% and 73.7%,respectively.The value of three combined tumor markers was not superior to the single CA199 asssy and the combined of CA199 and CEA assay,while increasing medical cost of patients.Although there was no significant difference between the CA199 positivity ratios of the jaundiced(33.3%) and non-jaundiced(18.8%) patient subgroups of the benign pancreatic diseases,this ratio was significantly higher in the jaundiced subgroup(78.9%) than the nonjaundiced subgroup(61.0%) of the pancreatic carcinoma(P < 0.05).The CEA and CA125 positivity ratios of jaundiced and non-jaundiced subgroups of patients with benign and malignant pancreatic diseases were not significantly different.Conclusion These results suggest that the combined of CA199 and CEA,which could be improve the sensitivity and specificity(P < 0.05),helaful to assess the pancreatic mass leisions.The blood jaundice level should be considered when using CA199 for the differential diagnosis of pancreatic neoplasm from benign pancreatic lesions;CA199 can be useful in the jaundiced patients,whereas CA125 and CEA provide a limited contribution in jaundiced patients.We can make a new set-point of CA199 for the diagnosis of pancreatic neoplasm by studying theROC curve and other statistic index to enhance the accuracy.

Diagnostic value of tissue polypeptide specific antigen in serum for patients with pancreatic carcinoma

Serology Detection's Diagnostic Value in Pancreatic Cancer

CLINICAL VALUE OF SERUM TUMOR MARKERS EXPRESSION IN DIAGNOSIS OF PANCREATIC CARCINOMA

Abnormal Expressions of Tissue Polypeptide Specific Antigen in the Serum of Patients with Prostate Cancer

An Evaluation of the Diagnostic Value of CA19-9 and CEA Levels in Patients with Pancreatic Cancer

Immunodiagnostic Value Of Combined Detection Of Autoantibodies To Tumor-Associated Antigens As Biomarkers In Pancreatic Cancer

Serological Characteristics Of Autoimmune Pancreatitis And Its Differential Diagnosis From Pancreatic Cancer By Using A Combination Of Carbohydrate Antigen 19-9, Globulin, Eosinophils And Hemoglobin

[Clinical value of serum TPS, CEA, Pro-GRP and CYFRA21-1 in patients with lung cancer]

Study on diagnostic significance of gastrointestinal tumor markers in patients with pancreatic cancer

The Systemic Assessment to the Clinical Value of Serum Tumor Markers for the Diagnosis of Pancreatic Cancer

Value of Tumor Markers in Differential Diagnosis of Pancreatic Mass Lesions

Role of combined Testing of Serum Tumor Markers in the Diagnosis and Treatment of Pancreatic Adenocarcinoma.

Complementarity Between Serum Tumor Markers in Pancreatic Carcinoma

The Levels and Clinical Significance of Tissue Polypeptide Specific Antigen(tps) in Serum of Patients with Non-Small Cell Lung Cancer(nsclc)

Serum tumor markers for pancreatic cancer

The Clinical Value of the Combined Measurement of Three Serum Tumor Markers in Breast Cancer

The Expression Leuel of CA15-3 and TPS of Patient with Mamumary Cancer and its Clinical Value

Clinical Significance of CA19-9 and CEA Detection in Diagnosis of Pancreatic Carcinoma

Evaluation of Serum ATX and LPA As Potential Diagnostic Biomarkers in Patients with Pancreatic Cancer

Diagnostic value of combined measurement of serum ULBP-2 and MIC-1 for pancreatic cancer

DIAGNOSTIC VALUE OF SERUM TUMOR MARKERS FOR LUNG CANCER